Spark to develop $575M Philadelphia gene therapy manufacturing plant. Trevena advances new pain drug; Ocugen receives good news from FDA. News ...
https://www.google.com/url?rct=j&sa=t&url=https://www.bizjournals.com/philadelphia/inno/stories/fundings/2021/12/20/20n-bio-malvern-3-3-million-seed-round-zhu.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNF6adfZOAEYR4DcegVizUDXqDWc_g
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.